Zetagen Therapeutics Announces Peer-reviewed Publication of In-Vivo Dose Optimization Findings for ZetaMast™ (Zeta-MBC-005) for Triple Negative Breast Cancer Liver Metastases
SYRACUSE, N.Y.--(BUSINESS WIRE)--Zetagen Therapeutics, a private, clinical-stage, biopharmaceutical company developing first-of-its-kind targeted therapies for primary and metastatic breast cancer, announced today the peer-reviewed publication in PLOS-One of their dose optimization in-vivo study results of ZetaMast™ (Zeta-MBC-005).
Zetagen identified two concentrations of ZetaMast™ (Zeta-MBC-005) which demonstrated superior effectiveness, reduction in tumor burden, and increased survival rate over control Doxorubicin.
' Patients with disseminated metastatic breast cancer involving the liver, face a poor prognosis and new approaches are urgently needed, ' stated Debasish Tripathy, MD, Professor and Chairman, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. ' Although some therapies have been designed for direct administration for liver metastases, they have not demonstrated efficacy in significantly improving survival. ZetaMast™ is an innovative therapeutic approach that has demonstrated systemic biological effects potentially extending beyond liver metastases in preclinical models, offering promising potential to enhance outcomes in this setting.'
ZetaMast™ (Zeta-MBC-005) Increased Survival in a Mouse Xenograft Liver Metastases Model. The 4T1, TNBC cell line, tagged with luc2 luciferase (4T1-luc2), was implanted directly into the liver of BALB/c mice. Seven days after tumor inoculation, mice were treated with various concentrations via a single administration of ZetaMast™ (Zeta-MBC-005) (30-, 60-, 120-, 180-, 240-, or 480-μg) in combination with 5-mg/kg doxorubicin. Mice in the Control group received 5 mg/kg of doxorubicin and the ZetaMast™ (Zeta-MBC-005) carrier without Zetagen's small molecule, administered every 72-hours.
ZetaMast™ (Zeta-MBC-005) has the ability to deliver Zetagen's small molecules intratumorally as well as other therapies, avoiding off-target side effects.
'Effective locoregional therapies are likely the key to reducing breast cancer mortality for patients with disseminated metastatic disease and increasing 5-year survival above 31%. If treatments like ZetaMast™ (Zeta-MBC-005) can be given when and where needed, increasing the duration of overall tumor control, which may be enough to tip the balance towards a favorable impact on survival,' stated Bryan S. Margulies, MS, Ph.D., CSO of Zetagen.
To view the ZetaMAST™ (Zeta-MBC-005) dose optimization study results go to https://doi.org/10.1371/journal.pone.0323621.
About ZetaMAST™ (Zeta-MBC-005)
ZetaMast™ (Zeta-MBC-005) is a proprietary drug eluting carrier designed for locoregional administration, controlled release of two small molecules in the treatment of multifocal, unresectable, liver metastases from breast cancer with the potential to increase survival rates.
The USPTO has granted Zetagen a 'Composition of Matter' patent for ZetaMast™ (Zeta-MBC-005), and Zetagen has also submitted a filing to the FDA for Orphan Drug Designation.
Zetagen is finalizing preparations for an FDA IND submission this fall, with a Phase 1b clinical trial set to commence early 2026.
About Zetagen Therapeutics
Zetagen has three novel drugs in development, ZetaMet™ (Zeta-BC-003), for the treatment of metastatic breast cancer to bone, ZetaMast™ (Zeta-MBC-005) for breast cancer liver metastases (BCLM), and (NEW) ZetaPrime™ (Zeta-PBC-007) for the treatment of primary HR+ breast cancer, all with inspiring results. To learn more, visit www.zetagen.com.
The FDA has acknowledged Zetagen's innovative research with multiple Breakthrough Designations, notably ZetaMet™ (Zeta-BC-003). Under FDA and Health Canada (HC) approval through the Expanded Access (Compassionate Use) programs, Zetagen has treated eight patients with ZetaMet™ (Zeta-BC-003), with results featured in several peer-reviewed journals. Furthermore, Zetagen has completed enrollment for its Phase 2a open-label clinical trial focused on treating metastatic breast cancer in the spine.
Zetagen Upcoming Events
Zetagen will attend the 2025 San Antonio Breast Cancer Symposium (SABCS).
Forward-Looking Statements
This press release contains certain forward-looking statements with the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions. Source: Zetagen Therapeutics, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
10 hours ago
- Business Upturn
NeuroEnergizer 2025 Update Launches: Binaural Beats Program Emerges as Leading Non-Stimulant Focus Solution
Austin, June 28, 2025 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE NeuroEnergizer, the pioneering binaural beats program for lifestyle-focused cognitive support, has unveiled its highly anticipated 2025 digital wellness update. This update, a result of extensive research and user feedback from our team of experienced neuroscientists and wellness experts, positions NeuroEnergizer™ at the forefront of portable focus enhancement technologies. It introduces enhanced stereo alignment, increased sound layer depth, and variable duration tracks to support both short bursts and extended productivity sessions. The company's latest release is designed for consumers seeking screen-free, non-stimulant tools to promote mental clarity and attention alignment in their daily lives. This update arrives as consumer search trends reflect a surge in interest around non-pharmacological cognitive support tools, with terms like 'binaural beats for focus,' 'brainwave entrainment for study,' and 'natural alternatives to ADHD supplements' dominating wellness discourse. NeuroEnergizer now steps forward with a fully digital, headphone-ready experience designed for the modern multitasker, remote worker, and mindful learner. What You'll Learn in This Release: What makes NeuroEnergizer™ the leading sound-based cognitive focus tool in 2025 Why binaural beats are trending as top natural productivity boosters How digital wellness is reshaping non-clinical mental performance support Where NeuroEnergizer™ fits into the emerging market of brainwave audio programs What consumers are saying about screen-free focus enhancement How sound frequency programs are outperforming traditional nootropics in user engagement Why remote workers and digital minimalists are driving the popularity of audio-first cognitive tools The Modern Attention Dilemma In an era where digital overload dominates the workday and mental distractions interrupt personal productivity, many individuals are seeking new tools to reclaim focus without relying on synthetic stimulants or screen-heavy solutions. This backdrop has given rise to a surge in digital wellness solutions that blend scientific inquiry with minimalist design—and among the most compelling are audio-based experiences, such as NeuroEnergizer™. The latest version of the NeuroEnergizer program provides a distraction-free path to clarity by utilizing structured auditory experiences that align with naturally occurring brainwave states. For individuals working remotely, studying for exams, or simply seeking relief from overstimulation, the appeal is clear: a straightforward, portable, and intuitive system to enhance concentration without chemical or visual disruption. Digital Wellness Meets Auditory Innovation As screen fatigue and overstimulation become modern-day epidemics, the demand for audio-first solutions has exploded. NeuroEnergizer's 2025 release features a curated collection of binaural beat soundtracks engineered for passive use—whether users are working, studying, or winding down for sleep. With no apps to download, no subscriptions to manage, and no stimulants to ingest, the program offers flexibility for those seeking self-directed focus routines. Compatible with all standard stereo headphones, the binaural beat tracks operate on structured frequency principles designed to align with natural brainwave states such as alpha (relaxed focus), beta (active thinking), and theta (deep relaxation). This solution is part of a growing class of non-visual, low-intervention cognitive aids that require minimal effort to adopt and utilize. By combining ease of access with a user-friendly design, NeuroEnergizer™ taps into the momentum behind minimalist wellness tools—resources that support without overwhelming. It meets the needs of users navigating attention fragmentation in environments filled with digital clutter, providing a comfortable and straightforward experience. SEO Trend Surge: Binaural Beats, ADHD Alternatives & Study Boosters Search engines are now flooded with user interest around: 'Binaural beats study playlist' 'Sound frequency focus hack' 'Natural attention support without meds' 'Audio-based ADHD alternatives' 'Digital brainwave entrainment program' These search patterns reflect a strong desire for auditory tools that don't require ingestibles, complicated wearables, or therapeutic enrollment. Instead, users are seeking natural sensory alignment—techniques that stimulate the brain without triggering screen fatigue, physiological stress, or dependency concerns. NeuroEnergizer™ directly aligns with this surge. As public curiosity grows around auditory modulation and its role in mental energy, programs like this are gaining traction for their simplicity, portability, and low-friction adoption. Several popular influencers have incorporated binaural beats into their morning productivity routines, and YouTube search data indicates a notable increase in demand for 'binaural beats for energy' and 'focus-enhancing background music.' These digital patterns suggest a robust market fit for portable programs like NeuroEnergizer™, which package precision soundscapes into lifestyle-friendly formats. Why NeuroEnergizer™ Matters in 2025 NeuroEnergizer™ is neither a supplement, a stimulant, nor a clinical intervention. It's a sound-based experience for those seeking: Cognitive calm without chemicals Focus without blue light Productivity without pressure Users receive a digital package including: High-quality binaural audio sessions A revised 2025 Quick Start listening guide Bonus tracks for evening relaxation and restorative sleep alignment The format is minimalist by design: no proprietary app, no recurring costs, and no algorithmic tracking. Listeners maintain full autonomy, applying the program based on their personal needs—a growing priority among wellness-aware consumers, empowering them to take control of their wellness journey and make decisions that best suit their lifestyle. Whether used during deep work blocks, pre-meeting grounding, or bedtime decompression, the 2025 NeuroEnergizer™ library provides brainwave synchronization for all central energy states without requiring a lifestyle overhaul. Public Reception & Market Signals Commentary across forums, wellness subreddits, and lifestyle blogs reveals a notable increase in interest in non-pharmaceutical attention aids. Consumers are especially drawn to: Passive-use digital wellness tools Auditory support without clinical gatekeeping Self-experimentation in focus optimization NeuroEnergizer™ consistently appears in side-by-side comparisons with mindfulness apps, focus timers, and guided meditations—yet it differentiates by being purely audio-driven, self-paced, and non-visual. In testimonials and informal reviews, users have cited improved 'flow state' entry, easier transition between tasks, and lower levels of sensory overload while working. While results vary, the common thread is empowerment—users choosing tools that support their routines rather than disrupt them. Reddit discussions point to binaural beats as an 'easy win' for people trying to detox from caffeine or Adderall dependencies. Others view it as a 'reset button' during burnout or screen exhaustion. The rise in long-form reviews and playlist sharing across platforms signals a cultural shift toward individualized, non-invasive enhancement tools. Technology Spotlight: How Binaural Beats Work NeuroEnergizer™ is built around binaural beats technology, a method of auditory stimulation where two tones of slightly different frequencies are played in each ear. The brain interprets the difference between the two frequencies as a rhythmic beat. This beat, perceived internally, is associated with changes in brainwave activity, potentially corresponding to relaxed, focused, or sleep-supportive mental states. In simpler terms, it's like a gentle massage for your brain, helping it relax, focus, or wind down, depending on your needs. Though clinical consensus on specific outcomes remains under exploration, many users report subjective improvements in: Mental clarity Focus duration Mood regulation The transition between cognitive tasks NeuroEnergizer™ enhances this base technology with carefully calibrated frequencies sequenced in a curated format to match different user goals—morning energy, afternoon concentration, or evening wind-down. The 2025 version introduces enhanced stereo alignment, increased sound layer depth, and variable duration tracks to support both short bursts and extended productivity sessions. In Context: The Rise of Sound-Enabled Wellness Tools From Spotify playlists titled 'brain boost' to YouTube channels dedicated to studying beats, the cultural interest in sound as a productivity ally is well established. However, few platforms provide curated experiences with purpose-built frequency design. NeuroEnergizer™ fills this gap by offering not just background audio but intentional sound environments backed by principles of brainwave entrainment. Its non-visual nature also makes it attractive to those battling overstimulation, digital burnout, or visual screen fatigue. In a world where most wellness apps push notifications and track behavior, NeuroEnergizer™ offers a frictionless alternative: start the track, put on your headphones, and go. Use Cases: Real-World Listening Scenarios NeuroEnergizer™ is designed for flexible integration into nearly any routine. From early morning startup rituals to mid-day focus blocks and pre-sleep decompression, users are embedding these sound sessions into: Remote Workflows: Professionals working from home use NeuroEnergizer™ to maintain attention during back-to-back meetings or project planning. Professionals working from home use NeuroEnergizer™ to maintain attention during back-to-back meetings or project planning. Academic Study Cycles: Students, especially those studying for high-stakes exams, incorporate binaural sessions during note review and essay writing. Students, especially those studying for high-stakes exams, incorporate binaural sessions during note review and essay writing. Creative Projects: Writers, designers, and content creators use tracks to spark ideation and minimize cognitive distractions. Writers, designers, and content creators use tracks to spark ideation and minimize cognitive distractions. Evening Wind-Downs: Listeners struggling with overstimulation or screen exposure unwind with theta-frequency tracks before bed. Listeners struggling with overstimulation or screen exposure unwind with theta-frequency tracks before bed. Focus Recovery: Neurodivergent users and individuals with attention challenges have reported using the tool to re-center after distractions or energy crashes. By offering a passive, customizable experience, NeuroEnergizer™ supports a wide demographic—from teenagers in academic settings to adults in creative or corporate roles—without requiring a lifestyle change or a rigid commitment. Availability The full NeuroEnergizer™ program is available now at: Includes: Immediate digital download Updated 2025 audio library Quick start listening guide Relaxation and sleep-focused bonus content Compatible with: All standard stereo headphones Mobile, desktop, or tablet audio systems Personal listening schedules (daily use optional) Product Use Transparency NeuroEnergizer™ is an informational, wellness-aligned product and should not be used as a substitute for medical diagnosis or treatment. The audio programs are offered as tools for general attentiveness, relaxation, and sensory calm—no outcomes are promised, and no prescriptions are required. The product is not intended to treat or cure any disease and should not be used as a substitute for professional guidance when needed. Disclaimer NeuroEnergizer™ is not intended to diagnose, treat, cure, or prevent any disease or condition. This program is offered for general educational and lifestyle enhancement purposes. Individual experiences may vary. Always consult a qualified professional before making wellness-related changes. Frequently Asked Questions Do binaural beats actually work for focus? While individual experiences vary, many users report increased focus, fewer distractions, and improved flow when listening to properly tuned binaural beats. NeuroEnergizer™ sequences frequencies based on common brainwave patterns associated with mental alertness. Is this program safe for daily use? Yes. NeuroEnergizer™ is designed as a passive wellness support tool. There are no known adverse effects from daily listening. Users are encouraged to follow the quick start guide for optimal session length and timing. What headphones are best for binaural beats? Any standard stereo headphones will work. Over-ear models may provide a more immersive experience, but earbuds are perfectly acceptable for on-the-go use. Can NeuroEnergizer™ replace ADHD medication or supplements? No. This program is not a substitute for medical care. It is intended as a complementary tool for those seeking non-pharmaceutical support strategies. Always consult a healthcare professional before making changes to a treatment plan. Can I use this with other wellness apps? Absolutely. Many users integrate NeuroEnergizer™ with mindfulness apps, journaling routines, or Pomodoro-style productivity tools. About the Company Founded with a focus on digital wellness innovation, NeuroEnergizer™ is a lifestyle audio brand dedicated to exploring sound-based tools for focus, calm, and attentional support. The company specializes in non-clinical, user-directed listening programs designed to complement modern routines through accessible, portable formats. Since its inception, NeuroEnergizer has contributed to the growing awareness of auditory technologies, such as binaural beats, and their potential role in individual wellness practices. All programs are developed with transparency in mind and are intended for informational use only. NeuroEnergizer™ does not provide treatment or diagnostic services. Future Outlook for Audio-Based Digital Wellness As consumer interest in sound-enabled tools continues to rise, NeuroEnergizer™ is exploring future iterations that integrate personalization, adaptive soundscapes, and wearable tech compatibility. The convergence of AI and biofeedback in audio wellness may soon enable users to dynamically generate binaural beats based on their mood, heart rate, or brainwave activity. Industry analysts suggest that binaural beats and audio therapeutics are poised to disrupt the mental wellness space in a similar way to how meditation apps have reshaped mindfulness. As more individuals seek practical, passive tools that don't demand screen time or external inputs, the market for frequency-based products is expected to grow exponentially. NeuroEnergizer™ aims to stay at the forefront of this shift by remaining transparent, user-led and committed to providing safe and empowering experiences. Contact Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Wire
a day ago
- Business Wire
Rocket Lab Completes Record Launch Turnaround From Launch Complex 1, Successfully Deploys 68 th Electron Mission
MAHIA, New Zealand--(BUSINESS WIRE)--Rocket Lab Corporation (Nasdaq: RKLB) ('Rocket Lab' or 'the Company'), a global leader in launch services and space systems, today successfully launched its 68th Electron rocket to deploy a single satellite to space for a confidential commercial customer. The mission was the second of two launches from the same launch site in less than 48 hours, a new launch record for the Company as it continues to deliver dedicated, repeatable and reliable access to space for satellite operators. The 'Symphony In The Stars' mission lifted-off from Rocket Lab Launch Complex 1 in Mahia, New Zealand on June 28 th (7:08 p.m./07:08 UTC) to deploy a single spacecraft to a 650km circular Earth orbit. The mission was the first of two dedicated launches for the new customer on Electron booked less than four months ago, with a second mission scheduled before the end of 2025. Rocket Lab has now completed four launches in June for commercial satellite constellation operators, underscoring Electron's consistent performance and rapid deployment capabilities as the world's leading small launcher: the 'Full Stream Ahead' mission on June 3 rd; 'The Mountain God Guards' mission on June 11 th; 'Get The Hawk Outta Here' launched on June 26 th UTC, and today's 'Symphony In The Stars' mission. Rocket Lab Founder and CEO, Sir Peter Beck, says: 'Electron has demonstrated once again that it is the gold standard for responsive and reliable space access for small satellites. The future of space is built on proven performance, and Electron continues to deliver against a stacked launch manifest this year. Congratulations to the team on achieving its fastest launch turnaround yet between two missions from Launch Complex 1. This launch was also a quick-turn mission to meet our customer's mission requirements, and we're looking forward to doing it again later this year.' 'Symphony In The Stars' was Rocket Lab's tenth Electron mission of 2025 and its 68th launch overall. With 100% mission success so far this year, Electron continues to deliver reliable deployment amid an increasing launch cadence and rapid contract-to-launch timelines. Launch images: About Rocket Lab Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier, and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, a family of spacecraft platforms, and the Company is developing the large Neutron launch vehicle for constellation deployment. Since its first orbital launch in January 2018, Rocket Lab's Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered over 200 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab's spacecraft platforms have been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the 'Securities Act') and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development, operational expansion and business strategy are forward-looking statements. The words 'believe,' 'may,' 'will,' 'estimate,' 'potential,' 'continue,' 'anticipate,' 'intend,' 'expect,' 'strategy,' 'future,' 'could,' 'would,' 'project,' 'plan,' 'target,' and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the 'SEC'), accessible on the SEC's website at and the Investor Relations section of our website at which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
Business Wire
a day ago
- Business Wire
Align Technology Connects With Over 2,000 Doctors and Practice Staff at the 2025 Invisalign ® Asia Pacific (APAC) Summit
BANGKOK--(BUSINESS WIRE)--Align Technology, Inc. ('Align') (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from the 2025 Invisalign ® Asia Pacific ('APAC') Summit held in Bangkok, Thailand, June 5 – 7, 2025. 'With more than 3 million Invisalign smiles across Asia Pacific, we know that this region sees some of the toughest clinical challenges in the field of dentistry,' said David Carr, Align executive vice president and managing director, APAC. 'The 2025 Invisalign Asia Pacific Summit underscores the importance of continued innovation and education. We are committed to working in partnership with doctors across the region in developing Invisalign treatment protocols that can help them transform smiles and change lives for even more patients.' Over three days, more than 2,000 doctors, practice team members, partners, and Align staff from across the region came together to explore the latest innovations in digital orthodontics and restorative dentistry. The summit featured over 60 expert speakers and more than 50 immersive breakout lectures and hands-on workshops, all designed to help doctors elevate clinical outcomes, streamline workflows, and grow their practices. Key topics covered include kids and teen, complex treatments, comprehensive dentistry and practice growth. 'This meeting provided us with a platform to connect with doctors across the full Asia Pacific region, encourage ongoing learning and sharing and showcase how our global innovations can support doctors in this market,' said Gigi Tsui, Align senior director, clinical, APAC. 'As we celebrate 20 million Invisalign smiles globally, including 3 million Invisalign smiles across the Asia Pacific region, it's critical that we continue to engage doctors for feedback and insights. This is fundamental to developing new innovations that meet the unique needs of doctors and patients across this region.' Attendees explored new developments across multiple interactive zones in the Innovation Hub, including: Kids and Teens: Featuring Invisalign First™, Invisalign® Palatal Expander System, and Invisalign® System with mandibular advancement featuring occlusal blocks ('MAOB'). ClinCheck® signature experience: Highlighting the 1-page Rx form (Flex Rx), preference templates, and ClinCheck ® Live Update. Comprehensive Dentistry: Showcasing iTero Lumina™ Pro dental imaging system, iTero™ intraoral scanner, Invisalign Smile Architect™, and Invisalign® Smile Video. Consumer & Branding: Demonstrating branding and tools to help doctors raise awareness of digital treatment options among patients of all ages. Clinical Excellence: Sharing clinical tools, evidence-based resources, education and insights available to doctors and staff. The summit also featured a Women Leadership session and provider recognition and lifetime achievement awardees. In addition to the core Asia Pacific Invisalign Summit, over 300 delegates across 78 universities also attended the Align APAC University Forum hosted at the renowned Chulalongkorn University in Bangkok. The forum served as a dynamic platform for cross-border collaboration and meaningful dialogue on how Align's evidence-based approach and cutting-edge innovations complements academic excellence and clinical training. Key highlights included keynote presentations by industry experts, interactive case-based discussions, resident showcases, and panels on integrating aligner therapy into university curriculum. The event also celebrated academic excellence with the APAC Case Challenge and Align research awards for APAC, while fostering peer-to-peer collaboration and inspiring the next generation of orthodontic leaders. About Align Technology, Inc. Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.
